BRUKER CORPORATION (NASDAQ: BRKR)

BRUKER CORPORATION

NASDAQ: BRKR (Bruker Corporation)

Last update: 04 Jun, 11:53PM

37.83

0.43 (1.15%)

Add to watchlist

Previous Close	37.40
Open	36.81
Volume	2,164,652
Avg. Volume (3M)	2,432,431
Market Cap	5,732,455,936

Price / Earnings (TTM)	71.38
Price / Earnings (Forward)	16.75
Price / Sales	1.68
Price / Book	3.19

52 Weeks Range	34.10 (-9%) — 72.94 (92%)
Earnings Date	4 Aug 2025 - 8 Aug 2025
TTM Dividend Yield	0.53%

Market Trend

		Short Term	Medium Term
Industry	Medical Devices (US)	Bearish	Mixed
	Medical Devices (Global)	Bearish	Mixed
Stock	Bruker Corporation	Bearish	Bearish

AIStockmoo Score

1.5

Analyst Consensus	1.0
Insider Activity	3.0
Price Volatility	1.5
Technical Moving Averages	0.0
Technical Oscillators	2.0
Average	1.50

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
BRKR	6 B	0.53%	71.38	3.19
MASI	8 B	-	-	9.24
LIVN	2 B	-	-	2.46
NVCR	2 B	-	-	5.61
ATEC	1 B	-	-	50.98
TNDM	1 B	-	-	8.85

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Sector	Healthcare
Industry	Medical Devices
Investment Style	Small Core
% Held by Insiders	31.97%
% Held by Institutions	82.09%

Ownership

Name	Date	Shares Held
Pallas Capital Advisors Llc	31 Mar 2025	9,495,686
London Co Of Virginia	31 Mar 2025	4,138,969

52 Weeks Range	34.10 (-9%) — 72.94 (92%)
Price Target Range	40.00 (5%) — 60.00 (58%)
High	60.00 (Wells Fargo, 58.60%)	Buy
Median	45.50 (20.28%)
Low	40.00 (Citigroup, 5.74%)	Hold
Average	47.33 (25.11%)
Total	2 Buy, 4 Hold
Avg. Price @ Call	39.11

Firm	Date	Target Price	Call	Price @ Call
Citigroup	22 May 2025	40.00 (5.74%)	Hold	36.34
Citigroup	07 Apr 2025	50.00 (32.17%)	Buy	38.70
Barclays	08 May 2025	46.00 (21.60%)	Buy	40.51
Barclays	10 Apr 2025	50.00 (32.17%)	Buy	38.07
Goldman Sachs	08 May 2025	45.00 (18.95%)	Hold	40.51
Stifel	08 May 2025	48.00 (26.88%)	Hold	40.51
UBS	08 May 2025	45.00 (18.95%)	Hold	40.51
Wells Fargo	17 Apr 2025	60.00 (58.60%)	Buy	36.28

Name	Avg. Buy ($)	Avg. Sell ($)	Net Quantity	Net Value ($)
LAUKIEN FRANK H	38.30	-	2,608	99,886
Aggregate Net Quantity				2,608
Aggregate Net Value ($)				99,886
Aggregate Avg. Buy ($)				38.30
Aggregate Avg. Sell ($)				-

Name	Holder	Date	Type	Quantity	Price	Value ($)
LAUKIEN FRANK H	Officer	06 Jun 2025	Buy (+)	2,608	38.30	99,886

Date	Type	Details
03 Jun 2025	Announcement	Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
03 Jun 2025	Announcement	Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
02 Jun 2025	Announcement	Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
02 Jun 2025	Announcement	Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
30 May 2025	Announcement	Bruker Launches Revolutionary timsOmniTM Mass Spectrometer
30 May 2025	Announcement	Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale
30 May 2025	Announcement	Bruker Corporation to Present at the Jefferies Global Healthcare Conference
28 May 2025	Announcement	Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology
15 May 2025	Announcement	Bruker Announces Quarterly Dividend
14 May 2025	Announcement	Bruker and 10x Genomics Reach Global Settlement of Patent Litigation
07 May 2025	Announcement	Bruker Reports First Quarter 2025 Financial Results
25 Apr 2025	Announcement	Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025
24 Apr 2025	Announcement	Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis
17 Apr 2025	Announcement	Bruker Introduces nVista 2P Miniature Microscope
16 Apr 2025	Announcement	Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring
11 Apr 2025	Announcement	Bruker Announces First Quarter 2025 Preliminary Revenue
11 Apr 2025	Announcement	Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing
07 Apr 2025	Announcement	Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System
07 Apr 2025	Announcement	Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR
02 Apr 2025	Announcement	Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
Show more

TTM Dividend Yield	0.53%
5Y Average Dividend Yield	0.28%
Payout Ratio	38.46%
Expected Next Dividend Payment	Sep 2025

Ex Date	Announcement Date	Payment Date	Details
16 Jun 2025	12 May 2025	27 Jun 2025	0.05 Cash
17 Mar 2025	18 Feb 2025	28 Mar 2025	0.05 Cash
02 Dec 2024	14 Nov 2024	16 Dec 2024	0.05 Cash
30 Aug 2024	08 Aug 2024	16 Sep 2024	0.05 Cash
03 Jun 2024	14 May 2024	17 Jun 2024	0.05 Cash
29 Feb 2024	15 Feb 2024	15 Mar 2024	0.05 Cash
30 Nov 2023	17 Nov 2023	15 Dec 2023	0.05 Cash
31 Aug 2023	09 Aug 2023	15 Sep 2023	0.05 Cash
31 May 2023	11 May 2023	16 Jun 2023	0.05 Cash
28 Feb 2023	16 Feb 2023	17 Mar 2023	0.05 Cash
30 Nov 2022	10 Nov 2022	16 Dec 2022	0.05 Cash
31 Aug 2022	11 Aug 2022	16 Sep 2022	0.05 Cash
31 May 2022	13 May 2022	17 Jun 2022	0.05 Cash
28 Feb 2022	17 Feb 2022	18 Mar 2022	0.05 Cash
30 Nov 2021	11 Nov 2021	17 Dec 2021	0.04 Cash
31 Aug 2021	05 Aug 2021	17 Sep 2021	0.04 Cash
28 May 2021	12 May 2021	18 Jun 2021	0.04 Cash
04 Mar 2021	17 Feb 2021	19 Mar 2021	0.04 Cash
30 Nov 2020	11 Nov 2020	18 Dec 2020	0.04 Cash
31 Aug 2020	06 Aug 2020	18 Sep 2020	0.04 Cash
29 May 2020	12 May 2020	19 Jun 2020	0.04 Cash
06 Mar 2020	-	20 Mar 2020	0.04 Cash
29 Nov 2019	-	20 Dec 2019	0.04 Cash
30 Aug 2019	-	20 Sep 2019	0.04 Cash
31 May 2019	-	21 Jun 2019	0.04 Cash
04 Mar 2019	-	22 Mar 2019	0.04 Cash
30 Nov 2018	-	21 Dec 2018	0.04 Cash
31 Aug 2018	-	21 Sep 2018	0.04 Cash
01 Jun 2018	-	22 Jun 2018	0.04 Cash
05 Mar 2018	-	23 Mar 2018	0.04 Cash
01 Dec 2017	-	22 Dec 2017	0.04 Cash
31 Aug 2017	-	22 Sep 2017	0.04 Cash
01 Jun 2017	-	23 Jun 2017	0.04 Cash
06 Mar 2017	21 Feb 2017	24 Mar 2017	0.04 Cash
01 Dec 2016	10 Nov 2016	23 Dec 2016	0.04 Cash
01 Sep 2016	-	23 Sep 2016	0.04 Cash
02 Jun 2016	13 May 2016	24 Jun 2016	0.04 Cash
02 Mar 2016	-	24 Mar 2016	0.04 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2025	0.100	2	0.26
2024	0.200	4	0.34
2023	0.200	4	0.27
2022	0.200	4	0.29
2021	0.160	4	0.19
2020	0.160	4	0.30
2019	0.160	4	0.31
2018	0.160	4	0.54
2017	0.160	4	0.47
2016	0.160	4	0.76
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2025	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	2.31%
Operating Margin (TTM)	8.62%
Diluted EPS (TTM)	0.520
Quarterly Revenue Growth (YOY)	11.00%
Quarterly Earnings Growth (YOY)	-65.80%

Total Debt/Equity (MRQ)	115.22%
Current Ratio (MRQ)	1.57
Operating Cash Flow (TTM)	294.50 M
Levered Free Cash Flow (TTM)	336.59 M

Return on Assets (TTM)	4.79%
Return on Equity (TTM)	4.76%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)